The global vascular access catheters market is estimated to achieve the valuation of USD 3.0 Billon by end of 2022 and is expected to expand at a 5.7% CAGR over the forecast period (2022 to 2032). As of 2021, the non-antimicrobial segment has led the global vascular access catheters market with total estimation of USD 2.2 Billion.
Market Outlook:
| Data | Market Insight |
|---|---|
| Estimated market Value 2022 | USD 3.0 billion |
| Estimated market Value 2032 | USD 5.3 billion |
| CAGR of 2022 to 2032 | 5.7 % |
| Market share of Top 5 countries | 57.0 % |
| Key Market players | AngioDynamics, C.R. Bard, Teleflex Incorporated, Kimal, B. Braun Melsungen AG, Vygon (UK) Ltd., Fresenius Kabi AG, Becton, Dickinson and Company, Argon Medical Devices, Inc., Boston Scientific Corporation, Cook Medical Incorporated, Medical Components, Inc., Medtronic PLC., Terumo Medical Corporation, NIPRO Medical Corporation, Angiodynamics, Edwards Lifesciences Corporation. |
A vascular access catheter, also known as central line catheter, is a long, thin, flexible tube used to draw blood and body fluids from vein, including intravenous fluids, drugs, or blood transfusions. Central access catheters are used to for administering medicines, fluids, nutrients, blood and blood products. Also, these catheters are used for measuring central venous pressure (CVP), haemodialysis and chemotherapy over a long period of time.
Dialysis catheters are categorized into three segments mainly, acute haemodialysis catheter, chronic haemodialysis catheter and peritoneal dialysis catheters. A dialysis catheter is mainly utilized for exchanging blood to and from a haemodialysis machine and a patient. The dialysis catheter contains two lumens: venous and arterial. Other products include peripherally inserted central catheter (PICC) and implantable port. An implantable port is implanted or placed below the skin during surgical procedures. Ports can be used for providing intravenous drugs, fluids, food, or collecting blood samples. Central venous catheters (CVC) considered in the report falls under tunnelled and non-tunnelled product category.
Tunnelled catheters are inserted subcutaneously from the site of the insertion. The catheter and its attachments are underneath the skin. The risk of infection is lower due to subcutaneous tunnelling to distal exit site. Whereas non-tunnelled catheters are mostly inserted through subclavian vein or internal jugular vein. The insertion method is percutaneous venepuncture.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Vascular access catheters market has achieved the value of USD 2.9 Billon in 2021, and is expected to expand at 5.7 % CAGR in terms of revenue over the forecast period (2022 to 2032). The vascular access catheters market has grown over a CAGR of 4.9% in the historic period from 2012 to 2021.
Growth of the global vascular access catheters market is mainly driven by rising adoption and growing demand for antimicrobial coated catheters, coupled with socio-economic factors such as increasing disease incidences due to growing ageing population. Increasing cases of cancer and chronic kidney disease is a major factor globally.
Further increasing the usage of new and advanced catheters in the developed regions, increase in prevalence of end stage renal diseases and rising numbers of vascular access surgeries are the trends expanding the global vascular access catheters market. Other prominent growth drivers are product innovations and increasing rates of hospitalisations.
Product category, insertion procedure, indication and the age of the patient are set to define the reimbursement landscape for vascular access catheters. Catheter manufacturers are expected to invest more on product design and quality to minimize the impact on patient safety.
Increasing cases of blood transfusions, growing demands of patients for central venous access, rise in the numbers of lifestyle related disorders and rising demands for technologically advanced vascular access devices are promising factors to propel the market in the forecast period.
Aforementioned factors are expected market drivers and anticipated to expand the market during the forecast period.
Implementation of tip location devices has improved the accuracy and efficiency of PICC and CVC insertion by helping physicians to position the PICC and CVC tip in proximity to the cardio arterial and large vein junction.
Increasing demand for central venous catheters, favorable support from government bodies in terms of reimbursement and commercialization of novel interventional solutions are major factors boosting collaborations and partnership agreements between manufacturers.
Companies in the central access devices market are making major investments in order to introduce innovative central venous catheter to capitalize on lucrative opportunities in the vascular access catheters market. Also, companies are working on key related issues such as prevention of thrombus formation and infection by introducing catheters with antimicrobial coatings.
The above mentioned factors are great prospects for manufacturers to raise the adoption rate of their products to create a strong consumer base and boost up the vascular access catheters market in forecast years.
High costs of antimicrobial coated catheters adversely affects its adoption in the consumers, the average cost of these catheters is three-four times more than the standard catheters. Thus, high cost of antimicrobial catheters is expected to hamper the growth of vascular access catheters market in the forecast period.
Significant risks and complications are associated with central venous catheterization procedures which can lead to mechanical complications such as bleeding, damage to blood vessel, arterial puncture, hematoma, and pneumothorax.
Infectious complications such as infection at the insertion site of the catheter, contamination of the catheter and haematogenous seeding of the catheter etc., ultimately results in low preference for the catheterization procedures in the patients, which can probably hinder the growth of vascular access catheters market in the coming times.
Catheter related blood stream infections with high costs of these devices is a major factor restraining growth of the market over the forecast period. Alongside, these devices causing infections, other concern is lack of education and training, new products coming in the market require proper training for their safe use, which is not only expensive but time consuming.
The above mentioned factors are probable constraints for the expansion of vascular access catheters market in the forecast period.
The USA. has dominated the North American vascular access catheters market in 2021 with the regional revenue share of nearly 86% and is expected to grow over a CAGR of 6.4 % during the forecast period.
Over the time, the USA. vascular access catheters market has tended to shift towards less expensive catheter devices with lower rate of failures. The midlines and extended dwell catheters have emerged as great alternatives for the PICC catheters, having longer dwell time with less invasion at lower cost than the latter one and it is expected that these devices will propel the USA market in the future.
As of 2021, the UK has led the vascular access catheters market in the European region, holding the majority of the market share of about 22.2%. Cancer is the one leading cause for the demand of vascular access devices in the UK, rising number of cancer cases has resulted in increased demand for central venous catheters and implantable ports for the treatment of chemotherapy. Increase in diseases is further expected to drive the market.
China held the majority share of about 43.3% of the East Asian vascular access catheters market by the end of 2021. The growing adoption rate of PTCS balloon catheters and CVC (central venous catheters) with minimally invasive procedures in removing the blockage of arteries and of such devices at reasonable costs, are major driving factors for the vascular access catheters market to grow in the future.
As per an article published in NCBI in 2019 as well as surveillance report published by China CDC in 2015, the mortality rate owing to cardiovascular disease in China is around 364.5 for every 1 lac population and that the overall CVD mortality rate has increased to 7.4%. Additionally, 47% of the total deaths in China is related to CVD which is closely related to the ageing population as well.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The PICC catheters has driven the product segment of vascular access catheters market by generating the revenue of over USD 900.0 Million as of 2021, and is expected to grow over a CAGR of 7.0% in the forecast years. The urge to reduce catheter related complications such as bloodstream infections and needle stick injuries, people are opting for catheter line insertion. Due to this the market of such relevant products is expected to boost in the coming years.
The non-antimicrobial catheters held the majority market share of over 75.0% of the total property segment market of global vascular access catheters market by the end of 2021. The property of non-antimicrobial catheters in preventing the bacterial growth over the surface of catheters and rise in prevalence of diseases resulting in more demands of vascular devices with non-antimicrobial property are the key drivers for the market expansion.
The double lumen catheters accounted for USD 1.8 B by the end of 2021, and is expected grow over the CAGR of 6.1% during the forecast period, owing to the increase in prevalence of urology disorders such as kidney stones, urinary/bowel incontinence. Such conditions have raised the demands for catheters for their diagnosis. Wide availability of products and less invasive procedures are some major factors contributing to the growth vascular access catheters market.
Based on end user, the hospital segment accounted highest at USD 1.7 Billion by the end of 2021. Increasing geriatric population and growing numbers of diseases and infections in the population has given rise to the adoption of catheters devices coupled with availability of highly skilled medical and healthcare professionals which has surged the patient’s preference toward hospitalization.
Advancements in biocompatibility, flexibility, and the adoption of novel materials are shaping the demand of such efficient and quality products in the vascular access catheters market.
Players in the vascular access catheters market are looking forward to expand their market and create strong hold in consumer base from long-term vascular access catheters (VACs). Manufacturers have benefitted from the growing understanding of the diagnosis of VAC-related infections. Technological advancements especially concerning to designs and materials have enabled healthcare workers to overcome complex VAC infection and complications. These factors are the prospects of new technologies in the vascular access catheters market.
Key pharma players proactively working in the vascular access catheters market include Cook Medical Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, B Braun Melsungen AG and others.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2012 to 2021 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania and Middle East & Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Rest of Latin America, UK, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries Rest of Europe, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Vietnam , Philippines , Australia, New Zealand, Turkey, GCC, South Africa, Israel, North Africa and Rest of MEA |
| Key Market Segments Covered | Product, application, end user, region |
| Key Companies Profiled | AngioDynamics; C.R. Bard; Teleflex Incorporated; Kimal; B. Braun Melsungen AG; Vygon (UK) Ltd.; Fresenius Kabi AG; Becton; Dickinson and Company; Argon Medical Devices, Inc.; Boston Scientific Corporation; Cook Medical Incorporated; Medical Components, Inc.; Medtronic PLC.; Terumo Medical Corporation; NIPRO Medical Corporation; Angiodynamics; Edwards Lifesciences Corporation |
| Pricing | Available upon Request |
The global vascular access catheters market is anticipated to achieve the valuation of about USD 5.3 Bn by the end 2032.
The global vascular access catheters market is expected to grow over a CAGR of 7.2% during the forecast period.
The North American region achieved the highest revenue share of around 45% in 2021.
As of 2021, the non-antimicrobial catheters have led the global vascular access catheters with the revenue share of over 75%.
C.R. Bard, Teleflex Incorporated, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical Incorporated, Medtronic PLC. are the major players in the market.
Increase in prevalence of chronic diseases, less invasive devices at reasonable costs, advancements in biocompatibility, flexibility, and the adoption of novel materials, innovations and research & development activities are the major driving factors for the global market.
The global market is estimated to reach the valuation of about USD 3.0 Bn by the end of 2022.
| Estimated Size in 2024 | USD 4.32 billion |
|---|---|
| Projected Value in 2034 | USD 8.02 billion |
| Value-based CAGR from 2024 to 2034 | 6.4% |
| Expected Market Value (2024) | USD 6,489.3 million |
|---|---|
| Market Value (2034) | USD 13,006.1 million |
| Estimated Growth (2024 to 2034) | 7.2% CAGR |
| Market Value for 2023 | USD 1,468.4 million |
|---|---|
| Market Value for 2033 | USD 2,466.5 million |
| Market Forecast CAGR (2023 to 2033) | 5.30% |
| Market Value (2023) | USD 454.8 million |
|---|---|
| Market Anticipated Value (2033) | USD 808 million |
| Market Projected CAGR (2023 to 2033) | 5.9% |
Explore Therapeutic Device Insights
View Reports
Vascular Access Catheters Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
